Loading...
NPI 1558518753 · Chula Vista, CA · Cardiovascular Disease Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Cardiovascular Institute Of San Diego Inc is a cardiovascular disease physician provider located in Chula Vista, California. This profile covers 0 Medicare and 72 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Cardiovascular Institute Of San Diego Inc |
| Address | 765 Medical Center Ct Ste 211 |
| City | Chula Vista |
| State | CA |
| ZIP | 91911 |
| Taxonomy | Cardiovascular Disease Physician |
| NPI Enumerated | August 19, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $129.2M |
| Medicare | $0 |
CARDIOVASCULAR INSTITUTE OF SAN DIEGO INC has no Medicare billing on file and reports $129.2M in lifetime Medicaid revenue, making its public billing footprint effectively single‑payer (Medicaid) in scale. This payer concentration has direct implications for negotiations, risk exposure, and population served because Medicare activity is absent from the available claims record.
Revenue is highly concentrated: the top three Medicaid codes (36478, 93229, 93306) account for 47.0% of the provider’s total Medicaid revenue. Those three codes individually generated $28.3M (36478, 22.4%), $16.9M (93229, 13.4%), and $14.2M (93306, 11.2%), highlighting a small set of services that drive nearly half of Medicaid receipts.
The mix of top codes indicates the practice operates as a high-volume cardiac and vascular diagnostic/interventional center: 36478 and 36465 reflect venous ablation/sclerotherapy activity (36478 $28.3M; 36465 $11.8M), while 93306, 93351, and 93356 show extensive echocardiography services (93306 $14.2M; 93351 $2.3M; 93356 $1.1M). Concurrently, codes for ambulatory cardiac monitoring (93229 $16.9M; 93298 $894.1K; $520.2K) demonstrate integrated remote and wearable monitoring workflows.
This provider is a dominant statewide player for many of its highest‑revenue procedures and diagnostics: 36478 ranks #1 of 18 providers in-state (100th percentile; extreme outlier), 93229 ranks #1 of 85 (100th percentile; extreme outlier), and 93306 ranks #1 of 1501 (100th percentile; extreme outlier). Those rankings indicate volumes far above typical state peers for these services and suggest market leadership in both venous procedures and ambulatory cardiac diagnostics.
Operational scale is evident in claim counts and routine diagnostic throughput: large claim volumes include 93306 with 64.3K claims, 99214 with 125K claims, 93000 with 61.4K claims, and 93229 with 20.2K claims. These figures point to a high‑throughput ambulatory platform that couples frequent office/ECG encounters with substantial imaging and monitoring capacity.
The revenue mix pairs very high‑cost device and procedure payments with high‑volume lower‑cost services: average paid/claim is elevated for procedures such as 36465 ($1565 avg paid/claim) and 36478 ($1535 avg paid/claim), and especially for device insertion 33285 ($4699 avg paid/claim), while monitoring and standard E/M codes produce lower per‑claim payments but large aggregate revenue. This combination results in both concentrated procedural revenue and broad diagnostic/monitoring cash flow.
While the provider is an extreme outlier statewide on many procedural and diagnostic codes, its participation in common E/M codes is more mixed: 99214 generates $10.4M and ranks #40 of 13295 providers in-state (100th percentile; extreme outlier), whereas 99215 ($906.5K) and 99213 ($617.3K) occupy more moderate percentiles (97th and 86th respectively). This suggests dominant procedural/diagnostic market share but a relatively more typical footprint on some routine office visit volumes.
The practice has been enumerated since 2008-08-19 (~18 years ago), indicating long tenure in the market. Combined with the concentrated Medicaid revenue profile and the pattern of dominant statewide ranks for specialty procedures, the record is consistent with an established specialty center focused on vascular and cardiac diagnostic/interventional services within the Medicaid population.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
72 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36478 | In this procedure, the provider inserts a specially designed laser ablation catheter probe through the skin and destroys the wall of a diseased vein in an extremity. The provider reports this code… | 18,460 | $1,540 | $28.3M |
| 93229 | In this procedure, the provider, typically a technician, places a wearable electrocardiographic monitoring device on the patient, instructs him in its use, and monitors the transmissions, to detect… | 20,170 | $840 | $16.9M |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 64,330 | $220 | $14.2M |
| 36465 | In this procedure, the provider injects a noncompounded foam sclerosing solution into a single incompetent truncal vein of the extremity under ultrasound guidance to guide the dispersion of foam,… | 7,540 | $1,570 | $11.8M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 125,010 | $80 | $10.4M |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 15,570 | $420 | $6.5M |
| 93970 | The provider performs an ultrasound scanning procedure called a duplex scan to characterize the pattern and direction of blood flow in extremity veins (arms or legs). This is a complete, bilateral… | 29,780 | $200 | $6M |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 15,480 | $330 | $5.1M |
| 33285 | The provider inserts a cardiac rhythm monitor with self–contained electrodes into a pocket in the tissues beneath the patient's skin and programs the device according to manufacturer’s directions. | 890 | $4,700 | $4.2M |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 22,130 | $130 | $2.9M |
Showing 1–10 of 72
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
72 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 36478 | In this procedure, the provider inserts a specially designed laser ablation catheter probe through the skin and destroys the wall of a diseased vein in an extremity. The provider reports this code… | 1 | 20 | 390 | $1,320 | $2.1M |
| 33285 | The provider inserts a cardiac rhythm monitor with self–contained electrodes into a pocket in the tissues beneath the patient's skin and programs the device according to manufacturer’s directions. | 1 | 10 | 440 | $3,880 | $1.8M |
| 36465 | In this procedure, the provider injects a noncompounded foam sclerosing solution into a single incompetent truncal vein of the extremity under ultrasound guidance to guide the dispersion of foam,… | 2 | 40 | 220 | $1,320 | $887.7K |
| 92971 | In this procedure, the provider assists the patient’s circulation by placing air cuffs around the lower extremities, which inflate and deflate in synchronization with the patient’s cardiac cycle. | 4 | 10 | 2,680 | $100 | $489.2K |
| 93229 | In this procedure, the provider, typically a technician, places a wearable electrocardiographic monitoring device on the patient, instructs him in its use, and monitors the transmissions, to detect… | 1 | 90 | 300 | $400 | $456.7K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 1 | 1,500 | 410 | $100 | $209.4K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 315 | 2,670 | 540 | $40 | $183.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | 13,300 | 640 | $40 | $169.6K |
| 93458 | In this procedure, the provider performs imaging supervision and interpretation for a coronary angiography with left heart catheterization and intraprocedural injections for left ventriculography. He… | 30 | 120 | 50 | $980 | $152.8K |
| 37252 | In this add–on procedure, the provider inserts a specially designed catheter with an ultrasound transducer, a device that sends high–frequency sound waves through the tissues and detects their… | 18 | 40 | 50 | $620 | $146K |
Showing 1–10 of 72
Other providers in the same ZIP code as Cardiovascular Institute Of San Diego Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.